Clinical practice. Heparin-induced thrombocytopenia.
Arepally
Gowthami M
GM
Department of Medicine, Division of Hematology, Duke University Medical Center, Durham, NC, USA.
Ortel
Thomas L
TL
D000465:Algorithms; D000906:Antibodies; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006496:Heparinoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010978:Platelet Factor 4 / Q000276:immunology; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000000981:diagnostic imaging; D011859:Radiography; D011994:Recombinant Proteins / Q000627:therapeutic use; D013917:Thrombin / Q000037:antagonists & inhibitors; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D000906:Antibodies; D000925:Anticoagulants; D006496:Heparinoids; D011994:Recombinant Proteins; D010978:Platelet Factor 4; D006493:Heparin; D013917:Thrombin